We are live on ! Find out more
NDRAW

ENDRA Life Sciences Inc. Warrants
NDRAW

Delisted

NDRAW was delisted on the 12th of May, 2022.

Back to rankings

1 hedge funds and large institutions have $6K invested in ENDRA Life Sciences Inc. Warrants in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$4.06K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$6K +$4.06K +4,410 New

NDRAW Hedge Fund Activity: Q4 2017 in Review

1 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences Inc. Warrants (NDRAW) for Q4 2017, worth a combined $6K.

Buyers outnumbered sellers: 1 fund opened new NDRAW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $4.06K.

  • 1 institutional investor held ENDRA Life Sciences Inc. Warrants (NDRAW) as of Q4 2017, up from 0 in Q3 2017.
  • Funds reported $6K of ENDRA Life Sciences Inc. Warrants stock for Q4 2017.
  • 1 fund opened new ENDRA Life Sciences Inc. Warrants positions in Q4 2017 and 0 closed out, a net change of +1 holder.
  • The largest ENDRA Life Sciences Inc. Warrants buyer in Q4 2017 was UBS Group, an estimated $4.06K added.

Based on aggregated 13F filings for Q4 2017.